A leading UK diabetes charity advancing care, research and policy
The NHS in England and Wales has approved teplizumab, the first drug that can delay onset of type 1 diabetes. The immunotherapy offers up to three extra years before symptoms require lifelong insulin, with rollout backed by NICE and a commercial deal with Sanofi.